Event Date/Time: Apr 22, 2010 | End Date/Time: Apr 23, 2010 |
Description
Day One
Stream One:
Drug Safety: Studying the elevated role of drug safety and toxicology and the new techniques and technologies available, with reference
to case studies from multiple therapeutic areas.
Stream Two:
Regulation and Risk/Benefit Assessments Overview: Exploring the latest regulation guidelines and global frameworks and
examining the increased importance in risk assessment and pharmacovigilence in reducing drug bottlenecks
Day Two
Stream One:
Pharmacology: Examining the best practices and optimization strategies in pharmacology and toxicology, including integrated strategies
and best practise case studies
Stream Two:
Translational & Personalised Therapeutics/Partnership and Outlining Strategies: Examining emerging areas of
personalised medicine including omics and patient stratification and exploring partnership and outsourcing strategies in the modern
pharmaceutical environment.
Who will attend:
120 senior attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, academics, government, CRO and solution provider companies will be attending. Meet Senior VPs, Directors, and Managers from the following job titles:
Biomarkers, Clinical Pharmacology, Regulatory Affairs, Pharmacogenomics, Clinical Research, CEO, ADME
Translational Medicine, Pre-Clinical Research, Strategic Alliances, Risk Management, R&D, Outsourcing Technology ,
Biological Sciences, Epigenomics, Screening, POC Imaging, Non-clinical Safety, Drug Development, Pharmacokinetics,
Pharma Development Discovery, Toxicology, Portfolio Strategy, PK/PD, Surveillance Modelling, Bioinformatics